FFA
TXG icon

Farther Finance Advisors’s 10x Genomics TXG Stock Holding History

Farther Finance Advisors’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$84.4K Buy
934
+215
+30% +$12.6K ﹤0.01% 3003
2026
Q2 		$27.5K Sell
719
-763
-51% -$20K ﹤0.01% 3729
2026
Q1 		$32.7K Buy
1,482
+811
+121% +$16.2K ﹤0.01% 3301
2025
Q4 		$10.9K Buy
671
+244
+57% +$3.69K ﹤0.01% 3847
2025
Q3 		$4.99K Buy
427
+16
+4% +$209 ﹤0.01% 3767
2025
Q2 		$4.76K Buy
411
+99
+32% +$902 ﹤0.01% 3375
2025
Q1 		$2.71K Buy
312
+54
+21% +$681 ﹤0.01% 3271
2024
Q4 		$3.71K Sell
258
-173
-40% -$2.73K ﹤0.01% 2785
2024
Q3 		$9.73K Buy
431
+92
+27% +$1.9K ﹤0.01% 2383
2024
Q2 		$6.3K Sell
339
-29
-8% -$759 ﹤0.01% 2284
2024
Q1 		$13.6K Buy
368
+242
+192% +$10.6K ﹤0.01% 1630
2023
Q4 		$7.05K Buy
126
+33
+35% +$1.44K ﹤0.01% 1791
2023
Q3 		$3.84K Buy
93
+40
+75% +$2.08K ﹤0.01% 1606
2023
Q2 		$2.96K Sell
53
-994
-95% -$53.8K ﹤0.01% 1618
2023
Q1 		$58.4K Buy
+1,047
New +$48.9K 0.02% 563

Other funds holding TXG

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
WPC
Wedmont Private Capital West Chester, Pennsylvania $4.18B AUM 18.65% 1-Year Est. Return
GAA
Green Alpha Advisors Niwot, Colorado $148M AUM 98.22% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
EWP
Elevation Wealth Partners Santa Rosa, California $356M AUM 17.04% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
GA
GoalVest Advisory New York $578M AUM 17.41% 1-Year Est. Return

Farther Finance Advisors's TXG Position: Q3 2026 in Review

Farther Finance Advisors increased its 10x Genomics (TXG) stake by 30% in Q3 2026, buying an estimated $12.6K and bringing the position to 934 shares worth $84.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3003.

Farther Finance Advisors first reported a position in TXG in Q1 2023 and has held it in 15 quarters since. 9 funds tracked by Wall St. Rank hold TXG as of Q3 2026.

  • Farther Finance Advisors held 934 shares of 10x Genomics worth $84.4K as of Q3 2026.
  • Farther Finance Advisors bought 215 10x Genomics shares in Q3 2026, an estimated $12.6K.
  • 10x Genomics made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3003 holding.
  • Farther Finance Advisors first reported a position in 10x Genomics in Q1 2023 and has held it in 15 quarters since.
  • 9 funds tracked by Wall St. Rank held 10x Genomics as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.